ESC Premium Access

Same day discharge after atrial fibrillation ablation is feasible and safe. Results of a prospective study in 1015 patients

Presentation

About the speaker

Mr Mindaugas Viezelis

Hospital of Lithuanian University of Health Sciences, Kaunas (Lithuania)
0 follower

23 more presentations in this session

Left atrial dysfunction still exists in patients who obtain normal left atrial volume after successful ablation of atrial fibrillation.

Speaker: Doctor H. Kawakami (Toon, JP)

Thumbnail

Benefits of early intervention with catheter ablation in patients with atrial fibrillation

Speaker: Doctor S. Mohanty (Austin, US)

Thumbnail

Cryoballoon ablation of atrial fibrillation in low and medium volume hospitals - experiences of the German REGIONAL registry

Speaker: Doctor J. Michaelsen (Lingen, DE)

Thumbnail

Accuracy comparison of the new and previous Kodex occlusion tool software versions to assess pulmonary vein occlusion in atrial fibrillation cryoablation

Speaker: Doctor M. Polselli (Rome, IT)

Thumbnail

Bystander dispatcher-assisted cardiopulmonary resuscitation for the likelihood of an initial shockable rhythm after out-of-hospital cardiac arrest

Speaker: Professor Y. Goto (Kanazawa, JP)

Thumbnail

Access the full session

Congress committee e-posters choice in arrhythmias and device therapy

Speakers: Mr M. Viezelis, Doctor H. Kawakami, Doctor S. Mohanty, Doctor J. Michaelsen, Doctor M. Polselli...
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

EHRA Premium Access

Selective epicardial pulsed field ablation of atrial ganglionated plexi causes anti-arrhythmic prolongation of refractoriness: demonstration of feasibility in cardiac surgery patients

3 April 2022

ESC Premium Access

Comparing Rivaroxaban and Apixaban in GARFIELD-AF according to ROCKET AF and ARISTOTLE trial selection criteria

27 August 2021

ESC Premium Access

Effectiveness and safety of non-vitamin K antagonist oral anticoagulants versus warfarin among nonvalvular atrial fibrillation patients with prior bleeding events

27 August 2021

This platform is supported by

logo Novo Nordisk